January 12-15, 2026 | San Francisco Marriott Marquis, CA
MLAB Biosciences is advancing a novel approach to muscular dystrophy that targets a fundamental yet overlooked driver of disease progression. The lead program is progressing through IND-enabling studies and is rapidly approaching the clinical stage.